Catalent lays off 130 staffers at massive Indiana facility being sold to Novo Nordisk

Despite a multi-billion-dollar takeover bid from Novo Holdings, contract manufacturer Catalent appears to be continuing with the internal restructuring scheme it unveiled last year.

Catalent will lay off approximately 130 staffers at its massive manufacturing and filling plant in Bloomington, Indiana, a company spokesperson confirmed over email Thursday.

The staff reductions are new and unrelated to the roughly 300 positions the company chopped as part of its cost-cutting campaign between October and December 2023.

“As part of Catalent’s commitment to driving long-term sustainable growth, the company has been focusing on increasing efficiencies and reducing costs across our business,” the spokesperson explained in an emailed statement.

Coupled with those efforts, Catalent made the “difficult, but necessary” decision to cut both current and open roles at the Bloomington site, she added.